BWXQQ - MORPINE SULFATE

Product Identification

Product ID:MORPINE SULFATE
MSDS Date:05/10/1993
FSC:6505
NIIN:00-149-0113
MSDS Number: BWXQQ

Responsible Party
STERLING WINTHROP INC SANOFI WINTHROP PHARMACEU
90 PARK AVE
NEW YORK, NY 10016-1302
US

Emergency Phone: 212-907-2000/800-223-5511

Info Phone: 212-907-2000/800-223-5511

Cage: GO573

Contractor
WINTHROP PHARMACEUTICALS
NEW YORK, NY 10156 US

Telephone: 212-907-2000

Cage: 63240

Ingredients

MORPHINE SULFATE *95-1*

CAS: 64-31-3

RTECS: QC8750000

Fraction By Weight: 0-1.5%


SODIUM METABISULFITE, SODIUM METABISULPHITE

CAS: 7681-57-4

RTECS: UX8225000

Fraction By Weight: <1%

ACGIH TLV: 5 MG/CUM


WATER

CAS: 7732-18-5

RTECS: ZC0110000

Fraction By Weight: >25%

Hazards

Routes of Entry: Inhalation:NO Skin:NO Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:MAY CAUSE ADVERSE CENTRAL NERVOUS,
GASTROINTESTINAL, CARDIOVASCULAR & GENITOURINARY SYSTEM REACTIONS.
MAY BE HABIT FORMING. PRODUCT MAY CAUSE ALLERGIC TYPE REACTION IN
CERTAIN SENSITIVE PEOPLE.
Explanation of Carcinogenicity:NONE
Effects of Overexposure:IRREGULAR/PERIODIC BREATHING,
SEDATION/DROWSINESS/MENTAL CLOUDING/DIZZINESS/LETHARGY/IMPAIRMENT
OF MENTAL & PHYSICAL
PERFORMANCE/ANXIETY/CONVULSIONS/FEAR/MIOSIS/DYSPHORIA/MOOD
CHANGES/RESPIRATORY DEPR ESSION/NAUSEA/VOMITING/INCREASED PRESSURE
IN THE BILIARY TRACT/CONSTIPATION/ORTHOSTAIC HYPOTENTION/FAINTING
(SEE SUPP)

First Aid

First Aid:EYES: FLUSH W/PLENTY OF WATER FOR 15 MINS. SKIN: WASH W/SOAP
& WATER. OBTAIN MEDICAL ATTENTION IN ALL CASES. NOTE TO PHYSICIAN:
PRIMARY ATTENTION SHOULD BE GIVEN TO THE REESTABLISHMENT OF
ADEQUATE RES PIRATORY EXCHANGE THROUGH PROVISION OF A PATENT AIRWAY
& INSTITUTION OF ASSISTED/CONTROLLED VENTILATION. NALOXONE
HYDROCHLORIDE IS A SPECIFIC & EFFECTIVE ANTAGONIST FOR RESPIRATORY
DEPRESSION.

Fire Fighting

Extinguishing Media:USE ANY EXTINGUISHING AGENT WHICH IS SUITABLE FOR
THE SURROUNDING FIRE.
Fire Fighting Procedures:USE NORMAL FIRE FIGHTING GEAR.

Accidental Release

Spill Release Procedures:CONTAIN BY PLACING PAPER TOWELS/A SUITABLE
ABSORBENT MATERIAL AROUND THE EDGES OF THE SPILL & WORK INWARD.
CAREFULLY SCOOP UP INTO A PROPERLY LABELED WASTE CONTAINER FOR
DISPOSAL. WASH AREA TO REMOVE FROM SURFACES.

Handling

Handling and Storage Precautions:THIS IS A PHARMACEUTICAL MATERIAL
AVAILABLE ONLY W/A PRESCRIPTION-USE ONLY AS DIRECTED.
Other Precautions:AVOID EYE CONTACT.

Exposure Controls

Respiratory Protection:NONE NORMALLY REQUIRED
Ventilation:NORMAL VENTILATION
Protective Gloves:NONE NORMALLY REQUIRED
Eye Protection:NONE NORMALLY REQUIRED
Work Hygienic Practices:USE GOOD PERSONAL HYGIENE-WASH HANDS & EXPOSED
SKIN THOROUGHLY AFTER USE.
Supplemental Safety and Health
SYMPTOMS CONT'D: TACHYCARDIA/CIRCULATORY DEPRESSION/PERIPHERAL
CIRCULATORY COLLAPSE/CARDIAC ARREST/URETERAL SPASM/SPASM OF VESICAL
SPHINCTERS/URINARY RETENTION.

Chemical Properties

Solubility in Water:COMPLETE
Appearance and Odor:COLORLESS SOLUTION

Stability

Stability Indicator/Materials to Avoid:YES
Stability Condition to Avoid:EXCESSIVE HEATING

Disposal

Waste Disposal Methods:DISPOSE OF IN ACCORDANCE W/LOCAL, STATE &
FEDERAL REGULATIONS.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.